BE901810A - Compositions de bromocriptine. - Google Patents
Compositions de bromocriptine.Info
- Publication number
- BE901810A BE901810A BE1/11199A BE1011199A BE901810A BE 901810 A BE901810 A BE 901810A BE 1/11199 A BE1/11199 A BE 1/11199A BE 1011199 A BE1011199 A BE 1011199A BE 901810 A BE901810 A BE 901810A
- Authority
- BE
- Belgium
- Prior art keywords
- bromocriptine
- pharmacies
- acceptable
- compositions
- bromocriptine compositions
- Prior art date
Links
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 title abstract 2
- 229960002802 bromocriptine Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000013270 controlled release Methods 0.000 abstract 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848405227A GB8405227D0 (en) | 1984-02-29 | 1984-02-29 | Bromocriptine compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE901810A true BE901810A (fr) | 1985-08-26 |
Family
ID=10557324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE1/11199A BE901810A (fr) | 1984-02-29 | 1985-02-25 | Compositions de bromocriptine. |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS60202812A (enExample) |
| AT (1) | AT387716B (enExample) |
| AU (2) | AU586621B2 (enExample) |
| BE (1) | BE901810A (enExample) |
| CA (1) | CA1256374A (enExample) |
| CH (2) | CH666406A5 (enExample) |
| DE (1) | DE3505743C2 (enExample) |
| DK (1) | DK175016B1 (enExample) |
| ES (1) | ES8705223A1 (enExample) |
| FR (1) | FR2560047B1 (enExample) |
| GB (1) | GB8405227D0 (enExample) |
| GR (1) | GR850506B (enExample) |
| HK (1) | HK85490A (enExample) |
| HU (1) | HU196121B (enExample) |
| IE (1) | IE58235B1 (enExample) |
| IL (1) | IL74459A (enExample) |
| IT (1) | IT1199948B (enExample) |
| LU (1) | LU85791A1 (enExample) |
| MX (1) | MX9203626A (enExample) |
| NL (1) | NL194231C (enExample) |
| NZ (1) | NZ211247A (enExample) |
| PH (1) | PH23266A (enExample) |
| PT (1) | PT80015B (enExample) |
| SE (2) | SE8500961L (enExample) |
| SG (1) | SG69390G (enExample) |
| ZA (1) | ZA851546B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61501511A (ja) * | 1984-03-21 | 1986-07-24 | アメリカン・ホ−ム・プロダクツ・コ−ポレイション | 徐放性医薬カプセル |
| DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
| DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
| KR100321649B1 (ko) * | 1993-03-17 | 2002-07-22 | 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 | 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE604564A (enExample) * | 1960-06-06 | |||
| CH507249A (de) * | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
| DE2553026A1 (de) * | 1974-12-04 | 1976-06-10 | Schlueter Edelfett | Neue formulierungen |
| CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
| IT1158162B (it) * | 1977-12-22 | 1987-02-18 | Sandoz Ag | Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina |
| DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| DE3216870A1 (de) * | 1982-05-03 | 1983-11-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische zubereitungen mit zytostatischer wirkung |
| US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
-
1983
- 1983-12-14 CH CH6660/83A patent/CH666406A5/de not_active IP Right Cessation
-
1984
- 1984-02-29 GB GB848405227A patent/GB8405227D0/en active Pending
-
1985
- 1985-02-14 HU HU85555A patent/HU196121B/hu unknown
- 1985-02-14 NL NL8500417A patent/NL194231C/nl not_active IP Right Cessation
- 1985-02-20 IT IT47703/85A patent/IT1199948B/it active
- 1985-02-20 DE DE3505743A patent/DE3505743C2/de not_active Expired - Lifetime
- 1985-02-22 CH CH830/85A patent/CH667009A5/de not_active IP Right Cessation
- 1985-02-22 FR FR8502716A patent/FR2560047B1/fr not_active Expired
- 1985-02-25 BE BE1/11199A patent/BE901810A/fr not_active IP Right Cessation
- 1985-02-26 CA CA000475119A patent/CA1256374A/en not_active Expired
- 1985-02-26 DK DK198500867A patent/DK175016B1/da active Protection Beyond IP Right Term
- 1985-02-26 AU AU39136/85A patent/AU586621B2/en not_active Expired
- 1985-02-27 JP JP60040277A patent/JPS60202812A/ja active Granted
- 1985-02-27 SE SE8500961D patent/SE8500961L/xx not_active Application Discontinuation
- 1985-02-27 LU LU85791A patent/LU85791A1/fr unknown
- 1985-02-27 SE SE8500961A patent/SE462259B/sv unknown
- 1985-02-27 PT PT80015A patent/PT80015B/pt unknown
- 1985-02-27 NZ NZ211247A patent/NZ211247A/xx unknown
- 1985-02-27 AT AT0058085A patent/AT387716B/de not_active IP Right Cessation
- 1985-02-27 GR GR850506A patent/GR850506B/el not_active IP Right Cessation
- 1985-02-27 IL IL74459A patent/IL74459A/xx not_active IP Right Cessation
- 1985-02-28 ES ES540807A patent/ES8705223A1/es not_active Expired
- 1985-02-28 ZA ZA851546A patent/ZA851546B/xx unknown
- 1985-02-28 PH PH31923A patent/PH23266A/en unknown
- 1985-02-28 IE IE49585A patent/IE58235B1/en not_active IP Right Cessation
-
1989
- 1989-05-19 AU AU35006/89A patent/AU618599B2/en not_active Expired
-
1990
- 1990-08-22 SG SG693/90A patent/SG69390G/en unknown
- 1990-10-18 HK HK854/90A patent/HK85490A/xx not_active IP Right Cessation
-
1992
- 1992-06-26 MX MX9203626A patent/MX9203626A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7378787A (en) | Controlled release pharmaceutical composition | |
| DE3583799D1 (de) | Feste zubereitung mit langsamer freisetzung. | |
| ES2192226T3 (es) | Composicion farmaceutica oral que contiene agentes activos antimicrobianos y pantoprazol de liberacion prolongada. | |
| DZ1078A1 (fr) | Formulation pharmaceutiques de substance labiles aux acides pour administration orale. | |
| ES8608864A1 (es) | Un procedimiento para producir un preparado a modo de hojas | |
| NL194821B (nl) | Farmacologisch actieve catecholderivaten en samenstellingen ervan. | |
| AU1810783A (en) | Constant release tablet formulation | |
| OA07621A (fr) | Forme orale de clométacine et sa préparation. | |
| ATE82118T1 (de) | Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung. | |
| DE3854148D1 (de) | Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten. | |
| ES2032770T3 (es) | Un procedimiento para producir farmacos de administracion nasal. | |
| MY101544A (en) | Pharmaceutical composition for external use containing active-type vitamin d3. | |
| OA06533A (fr) | Dérivés de la pyrimidine, procédés pour leur préparation, compositions pharmaceutiques contenant ces composés et leur utilisation thérapeutique. | |
| MY101029A (en) | Bromocriptine compositions | |
| SE8400723L (sv) | Farmaceutisk komposition | |
| OA09137A (fr) | Nouveaux dérivés de la benzoxazolinone, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. | |
| BE904152A (fr) | Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle. | |
| FR2571369B1 (fr) | Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant | |
| IE831030L (en) | Benzopyrans and benzothiopyrans | |
| IT1196958B (it) | Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche | |
| OA08734A (fr) | Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant. | |
| IT1213034B (it) | Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale. | |
| IT8521528A0 (it) | Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo. | |
| FR2685204B1 (fr) | Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine. | |
| IT8621135A0 (it) | Derivati dell'acito cef-3-em-4-carbossilico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: *NOVARTIS A.G. Effective date: 20050225 |
|
| RE20 | Patent expired |
Owner name: *NOVARTIS A.G. Effective date: 20050225 |